Treace Medical Concepts, Inc. (TMCI)
2.86
+0.08
(+2.88%)
USD |
NASDAQ |
Dec 10, 16:00
2.875
+0.02
(+0.52%)
After-Hours: 20:00
Treace Medical Concepts EPS Diluted (Quarterly): -0.2564 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.29M |
| Revenue (Quarterly) | 50.21M |
| Total Expenses (Quarterly) | 66.50M |
| Enterprise Value | 195.19M |
| Gross Profit Margin (Quarterly) | 79.07% |
| Profit Margin (Quarterly) | -32.44% |
| Earnings Yield | -27.78% |
| Normalized Earnings Yield | -27.76 |